[Helicobacter pylori and hepatic encephalopathy]

Area of Science:

• Hepatology
• Gastroenterology
• Microbiology

Background:

• Hepatic encephalopathy (HE) is a complex neurological complication of severe liver dysfunction.
• Elevated ammonia levels are a key factor in HE pathogenesis.
• Helicobacter pylori (H. pylori), due to its urease activity, is a potential contributor to ammonia production.

Purpose of the Study:

• To review current literature on the association between H. pylori infection and HE.
• To evaluate the evidence regarding H. pylori's role in ammonia metabolism and HE development.
• To assess the potential therapeutic benefit of H. pylori eradication in managing HE.

Main Methods:

• Systematic review of existing studies.
• Analysis of research investigating H. pylori prevalence in HE patients.
• Evaluation of studies on blood ammonia levels before and after H. pylori eradication.

Main Results:

• The relationship between H. pylori and blood ammonia levels in HE is currently inconclusive.
• Contradictory findings exist regarding the prevalence of H. pylori in patients with HE.
• Evidence on the efficacy of H. pylori eradication for improving HE symptoms is limited and inconsistent.

Conclusions:

• Further research is needed to clarify the role of H. pylori in HE pathogenesis.
• The therapeutic impact of H. pylori eradication on HE requires more robust investigation.
• Current data do not definitively support or refute H. pylori eradication as a standard HE management strategy.